Engineer Medical

ERIK N. GLASER

** ****** ****** *******, ** *****

Home: 781-***-**** Mobile: 781-***-**** *************@*****.***

INVESTMENT BANKING & COMMERCIAL STRATEGY - MEDICAL TECHNOLOGY

Results-driven professional with extensive commercial experience in medical technology - offering a broad range of

expertise in commercialization, operations, and market development. Able to successfully lead and execute projects in

cross-functional teams within Fortune 500 and start-up companies. Proven ability to develop strategic partnerships and

create new commercial opportunities in the med tech space. Transaction experience in med tech investment banking

including strategic market analysis. Master’s Degree in Biomedical Engineering and an MBA.

PROFESSIONAL HISTORY

Foster-Miller, Waltham, MA Sept 2008 - Present

STAFF CONSULTANT, MEDICAL DEVICE COMMERCIALIZATION

Develop licensing and joint venture opportunities to commercialize the portfolio of medical technologies. Create and

execute the strategic vision for the company’s medical technology business unit .

Medical Capital Advisors, LLC, Waltham, MA March 2008 - Present

SENIOR ASSOCIATE

Lead and support M&A transactions for a healthcare technology investment bank / merchant bank. Manage client

relationship in preparation for sell-side transaction process. Create business plans and market strategies for M&A clients

and Med Cap portfolio companies. Prepare M&A analytics to define and communicate deal structure with strategic

buyers/investors and C-level management of client companies.

Market Analytics - Research and create market sizing/segmentation models and product adoption models to

develop pro forma financial projections.

Financial Analytics - Create pro forma P+L models for deal structuring and valuation analysis using DCF and

industry comparables.

Strategy Analytics - Develop comprehensive commercial strategies that address key market drivers including

market size and dynamics, reimbursement, competitive advantage, and competitive landscape.

LeMaitre Vascular, Burlington, MA Jan 2008 - Feb 2008

DIRECTOR OF BUSINESS DEVELOPMENT

(Affected by a 40 person reduction in force in Feb 2008)

OmniSonics Medical Technologies, Wilmington, MA April 2005 - Dec 2007

SENIOR PROGRAM MANAGER / NEW MARKET DEVELOPMENT

Recruited to revive a failing product development program to restore credibil ity with the board of a medical device start-

up company. Promoted into a senior leadership role charged with creating a new program for an ischemic stroke

indication.

Joint Venture - Secured a $15M joint-venture with Boston Scientific’s Target division for a new ischemic stroke

opportunity. Managed and executed all pre-concept work including defining the market opportunity, customer

needs, technology development, budgeting, and program planning using Microsoft Project.

Program Leadership & Teamwork - Led an 18 member cross-functional team to achieve on-time 510(k) approval

and execute the first US product launch. Coordinated and executed all product development activities to achieve

commercial launch.

ERIK N. GLASER

Home: 781-***-**** Mobile: 781-***-**** *************@*****.*** Page 2

NMT Medical, Inc., Boston, MA Jan 2002 - April 2005

IMPLANT PROGRAM MANAGER

Program leader for the next-generation Class III implant platforms for percutaneous closure of the Patent For amen Ovale

(PFO). Managed and executed all aspects of product development including planning, R&D, pilot production, regulatory

affairs, and clinical study design.

Program & Project Management - Executed the product development of the BioSTAR implant into the BEST

clinical trial for CE mark. Concurrently executed product development of the BioTREK bioresorbable implant

into successful animal trials.

Scientific Collaborations - Led and executed research projects with world-renowned scientists (clinicians,

hematologists, and pathologists) to assess the safety profile of a tissue-engineered implant with a drug coating.

Recognized Innovator - One issued patent and two patent applications pending with the USPTO.

Cordis Corporation, Warren, NJ Jan 2001 - Dec 2001

SENIOR ENGINEER

Executed and completed the product development cycle for the entire product line of Palmaz Genesis endovascular

stents.

Product Development Leadership - Led the design verification and validation efforts to support the 510(k) fil ing.

Global Teamwork - Managed product development relationships with engineers at the Cordis facility in

Rotterdam, Netherlands.

Guidant Corporation - Vascular Intervention, Santa Clara, CA Dec 1996 - Dec 2000

PRECLINICAL R&D ENGINEER / SENIOR R&D ENGINEER

Managed labs and simulated use tests with Key Opinion Leaders to accelerate product development and promote

adoption of new stent and catheter product lines. Promoted to senior technical role to research and identify ‘white-space’

opportunities in interventional cardiology.

New Ventures - Researched and developed disruptive technology platforms to serve new markets in cardiovascular

medicine including local drug delivery and vulnerable plaque.

Customer Interface - Lead preclinical testing efforts with clinicians to bridge customer requirements with product

development capabilities to improve catheter and stent designs.

Corporate Impact - Developed innovative test methods for preclinical testing of stent and catheter prototypes.

Revolutionized preclinical testing capabilities across all global business units and the international training center in

Brussels, Belgium to reduce animal study costs by $100,000 in the year 2000.

EDUCATION

F.W. OLIN GRADUATE SCHOOL OF BUSINESS, BABSON COLLEGE, Babson Park, MA

Master of Business Administration - 2008

Cum Laude with an emphasis on Finance and Entrepreneurship

THE OHIO STATE UNIVERSITY, Columbus, OH

Master of Science, Biomedical Engineering - 1996

Graduate Research Assistant, The Cleveland Clinic Foundation, Cleveland, OH

THE OHIO STATE UNIVERSITY, Columbus, OH

Bachelor of Science, Materials Science and Engineering - 1993

Contact this candidate